McCormick Scientific Overview

  • Founded
  • 2005
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 2
  • Investments
  • 2

McCormick Scientific General Information

Description

Developer and manufacturer of histotechnology tools needed to support cancer screening technologies. The company conducts testing and research works on tissue processing and histopathology tests that are used to diagnose, identify and differentiate various forms of cancer using microscopic tissue samples.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Discovery Tools (Healthcare)
Primary Office
  • 5918 Evergreen Boulevard
  • Berkeley, MO 63134
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

McCormick Scientific Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore McCormick Scientific‘s full profile, request access.

Request a free trial

McCormick Scientific Executive Team (4)

Name Title Board Seat Contact Info
Douglas Martin Chief Executive Officer & President
Wayne Kozlen Chief Financial Officer
James McCormick MD Chief Scientific Officer & Partner
You’re viewing 3 of 4 executive team members. Get the full list »

McCormick Scientific Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore McCormick Scientific‘s full profile, request access.

Request a free trial

McCormick Scientific Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000000 01-Dec-2005 0000000000 Other Healthcare Technology Systems 0000000 000000
Tyco International (Paraplast) 07-Jan-2005 Buyout/LBO 00.00 Discovery Tools (Healthcare) 0000000 000000
To view McCormick Scientific’s complete investments history, request access »